Clinical trials: Healthy Elderly Subjects (Age ≥55 Years)
Healthy Elderly Subjects (Age ≥55 Years)
A Phase 1, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN003 in Healthy Elderly Subjects
This is a Phase 1, randomised, single-blind, placebo-controlled, 2 stage study design with 2 multiple dose cohorts of healthy elderly subjects.
- Trial name
- NCT02342652
- Testing
- ASLAN003
- Where
- Singapore
- Volunteers
- 7 people, healthy volunteers welcome
- Sponsor
- ASLAN Pharmaceuticals